(Q45877417)

17 December 2017

title

Viral IL-10 gene therapy inhibits TNF-alpha and IL-1 beta, not IL-6, in the newborn endotoxemic mouse (English)

1 reference

17 December 2017

0 references

0 references

Drazan KE

1

1 reference

17 December 2017

Wu L

series ordinal

2

1 reference

17 December 2017

Bullington D

series ordinal

3

1 reference

17 December 2017

Shaked A

series ordinal

4

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

17 December 2017

Journal of Pediatric Surgery

published in

1 reference

17 December 2017

volume

31

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

411-414

1 reference

17 December 2017

Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Interleukin-10 production during septicaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Modified immunological status of anti-IL-10 treated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Interleukin 10 protects mice from lethal endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Gene therapy of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Evolving principles in immunopathology: interleukin 10 and its relationship to Epstein-Barr virus protein BCRF1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Hepatic function is preserved following liver-directed, adenovirus-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Interleukin-6 elevation in critically ill infants with sepsis and necrotizing enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Transduction of Hepatic Allografts Achieves Local Levels of Viral IL-10 Which Suppress Alloreactivity in Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

Plasma cytokine levels in necrotizing enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990749-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3468(96)90749-6

1 reference

17 December 2017

1 reference

17 December 2017